Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
A relatively small number of endothelial progenitor cells have a profound effect on tumor growth and metastasis.
The authors are at Howard Hughes Medical Institute, Weill Cornell Medical College, New York, NY 10065, USA. E-mail: dcl2001{at}med.cornell.edu; srafii{at}med.cornell.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
REPORTS
Dingcheng Gao, Daniel J. Nolan, Albert S. Mellick, Kathryn Bambino, Kevin McDonnell, and Vivek Mittal (11 January 2008) Science319 (5860), 195.
[DOI: 10.1126/science.1150224] |Abstract »|Full Text »|PDF »|Supporting Online Material »
In Science Signaling
EDITORS' CHOICE
Paula A. Kiberstis (15 January 2008) Sci. Signal.1 (2), ec21.
[DOI: 10.1126/stke.12ec21] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Suppression of Tumor Angiogenesis by G{alpha}13 Haploinsufficiency.
L. Chen, J. J. Zhang, S. Rafii, and X.-Y. Huang (2009)
J. Biol. Chem.
284, 27409-27415
|Abstract »|Full Text »|PDF »
High Levels of Circulating VEGFR2+ Bone Marrow-Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies.
M. Taylor, J. Rossler, B. Geoerger, A. Laplanche, O. Hartmann, G. Vassal, and F. Farace (2009)
Clin. Cancer Res.
15, 4561-4571
|Abstract »|Full Text »|PDF »
CEACAM1+ myeloid cells control angiogenesis in inflammation.
A. K. Horst, T. Bickert, N. Brewig, P. Ludewig, N. van Rooijen, U. Schumacher, N. Beauchemin, W. D. Ito, B. Fleischer, C. Wagener, et al. (2009)
Blood
113, 6726-6736
|Abstract »|Full Text »|PDF »
Stem Cells and the Natural History of Lung Cancer: Implications for Lung Cancer Screening.
R. J. van Klaveren, S. C. van't Westeinde, B.-J. de Hoop, and H. C. Hoogsteden (2009)
Clin. Cancer Res.
15, 2215-2218
|Abstract »|Full Text »|PDF »
Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses.
P. Mancuso, P. Antoniotti, J. Quarna, A. Calleri, C. Rabascio, C. Tacchetti, P. Braidotti, H.-K. Wu, A. J. Zurita, L. Saronni, et al. (2009)
Clin. Cancer Res.
15, 267-273
|Abstract »|Full Text »|PDF »
Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin.
F. Pastorino, D. Di Paolo, F. Piccardi, B. Nico, D. Ribatti, A. Daga, G. Baio, C. E. Neumaier, C. Brignole, M. Loi, et al. (2008)
Clin. Cancer Res.
14, 7320-7329
|Abstract »|Full Text »|PDF »
Assessing Identity, Phenotype, and Fate of Endothelial Progenitor Cells.
K. K. Hirschi, D. A. Ingram, and M. C. Yoder (2008)
Arterioscler Thromb Vasc Biol
28, 1584-1595
|Full Text »|PDF »
Migratory neighbors and distant invaders: tumor-associated niche cells.
J. Wels, R. N. Kaplan, S. Rafii, and D. Lyden (2008)
Genes & Dev.
22, 559-574
|Abstract »|Full Text »|PDF »